Simon Voelkl
Impact in
- Immunology top 2%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Papers in
- Immunology 20
- Immune Cell Function and Interaction 13
- T-cell and B-cell Immunology 8
- Immunotherapy and Immune Responses 6
- Biosimilars and Bioanalytical Methods 2
- Oncology 12
- CAR-T cell therapy research 11
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Andréas Mackensen (22 shared papers)Reinhard Andreesen (6 shared papers)Karin Fischer (6 shared papers)Leoni A. Kunz‐Schughart (2 shared papers)Stefan W. Krause (2 shared papers)Norbert Meidenbauer (1 shared paper)Sabine Hoves (1 shared paper)Petra Hoffmann (1 shared paper)
- Journals
- Blood (15 papers)Cancer Immunology Immunotherapy (2 papers)Cancers (1 paper)Stem Cells (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Simon Voelkl
21 papers receiving 2.3k citations
Simon Voelkl's Hit Papers
Peers
Comparison fields: 5 of 100
- Immunology 1.1k
- Cancer Research 705
- Oncology 741
- Molecular Biology 768
- Biotechnology 74
Countries citing papers authored by Simon Voelkl
This map shows the geographic impact of Simon Voelkl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Voelkl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Voelkl more than expected).
Fields of papers citing papers by Simon Voelkl
This network shows the impact of papers produced by Simon Voelkl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Voelkl. The network helps show where Simon Voelkl may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Voelkl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibitory effect of tumor cell–derived lactic acid on human T cells Hit paper breakdown → | 2007 | 1507 |
| 2 | 2006 | 252 | |
| 3 | 2004 | 216 | |
| 4 | 2006 | 138 | |
| 5 | 2011 | 86 | |
| 6 | 2008 | 32 | |
| 7 | 2011 | 30 | |
| 8 | 2010 | 22 | |
| 9 | 2008 | 18 | |
| 10 | 2023 | 9 | |
| 11 | 2019 | 8 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 5 | |
| 14 | 2021 | 3 | |
| 15 | 2006 | 2 | |
| 16 | 2018 | 2 | |
| 17 | 2005 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2008 | 1 | |
| 20 | 2022 | 1 |
About Simon Voelkl
Simon Voelkl is a scholar working on Immunology, Oncology, Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 23 papers that have together received 2.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (13 papers), CAR-T cell therapy research (11 papers), T-cell and B-cell Immunology (8 papers), Immunotherapy and Immune Responses (6 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Biosimilars and Bioanalytical Methods (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Immunology (1.1k citations), Cancer Research (705 citations), Oncology (741 citations), Molecular Biology (768 citations) and Biotechnology (74 citations). Simon Voelkl has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Andréas Mackensen, Reinhard Andreesen, Karin Fischer, Leoni A. Kunz‐Schughart, Stefan W. Krause, Norbert Meidenbauer, Sabine Hoves, Petra Hoffmann, Julia Ammer and Matthias Edinger. Their work appears in journals such as Blood, Cancer Immunology Immunotherapy, Cancers, Stem Cells and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.